Eye Blood Flow Could Be Marker for Migraine

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Jan. 17, 2024 -- Blood flow appears to be reduced in the eye during migraine attacks, according to a study published online Nov. 30 in Headache: The Journal of Head and Face Pain.

Katherine Podraza, M.D., Ph.D., from the University of California, Los Angeles, and colleagues used optical coherence tomography angiography (OCTA) to determine if there are changes in structure and function of the retinal vasculature during and between migraine attacks. The analysis included 37 patients with migraine with aura (MA), 30 with migraine without aura (MO), and 20 healthy controls.

The researchers found a significant difference in the parafoveal vessel flux index (VFI) in the ictal state between the groups. There was a significant reduction in the parafoveal region VFI in MA during migraine attacks (−7 percent), as well as in MO (−7 percent) from their interictal baseline compared with controls. The MA group experienced a mean 13 percent lower blood perfusion interictally in the foveal region compared with the MO group. There was also higher circularity in the superficial foveal avascular zone in the MA group versus the MO group. Compared with the contralateral eye, patients with MA or MO and unilateral headache showed increased retinal vascular parameters consistent with greater perfusion in the eye ipsilateral to the side of the pain.

"These results indicate that changes in retinal perfusion could be a part of migraine pathophysiology, and that distinct retinal vascular signatures identified with OCTA could represent biomarkers for migraine," the authors write.

Several authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords